Opus Genetics Stock Analysis

Opus Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company recorded a loss per share of 1.86. Opus Genetics last dividend was issued on the 6th of November 2020. The entity had 1:4 split on the 6th of November 2020. To learn more about Opus Genetics call MBA MD at 984 884 6030 or check out https://opusgtx.com.

Opus Genetics Investment Alerts

Opus Largest EPS Surprises

View All Earnings Estimates

Opus Genetics Environmental, Social, and Governance (ESG) Scores

Opus Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 143.45 M.

Opus Profitablity

Management Efficiency

Opus Genetics has Return on Asset of (0.6074) % which means that on every $100 spent on assets, it lost $0.6074. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (3.3875) %, meaning that it generated no profit with money invested by stockholders. Opus Genetics' management efficiency ratios could be used to measure how well Opus Genetics manages its routine affairs as well as how well it operates its assets and liabilities. As of January 8, 2026, Return On Tangible Assets is expected to decline to -1.47. The current year's Return On Capital Employed is expected to grow to -2.65. At present, Opus Genetics' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Asset Turnover is expected to grow to 0.30, whereas Total Current Assets are forecasted to decline to about 33.9 M.

Technical Drivers

As of the 8th of January, Opus Genetics holds the Risk Adjusted Performance of 0.0542, coefficient of variation of 1610.55, and Semi Deviation of 3.61. Opus Genetics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Opus Genetics information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Opus Genetics is priced some-what accurately, providing market reflects its current price of 2.11 per share. Please also confirm Opus Genetics total risk alpha, which is currently at (0.11) to check out the company can sustain itself at a future point.

Opus Genetics Price Movement Analysis

Opus Genetics Insider Trading Activities

Opus Genetics Outstanding Bonds

Opus Genetics Predictive Daily Indicators

Opus Genetics Forecast Models

Opus Genetics' time-series forecasting models are one of many Opus Genetics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Opus Genetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Opus Genetics Bond Ratings

Opus Genetics financial ratings play a critical role in determining how much Opus Genetics have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Opus Genetics' borrowing costs.

Opus Genetics Total Assets Over Time

Opus Genetics Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Opus Genetics uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Opus Genetics Debt Ratio

56.0

It looks as if about 43% of Opus Genetics' assets are financed be debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Opus Genetics' operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Opus Genetics, which in turn will lower the firm's financial flexibility.

Opus Genetics Corporate Bonds Issued

Opus Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Opus Genetics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Opus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Opus Genetics. By using and applying Opus Stock analysis, traders can create a robust methodology for identifying Opus entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Opus analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Opus analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Opus Genetics stock analysis indicators help investors evaluate how Opus Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Opus Genetics shares will generate the highest return on investment. By understating and applying Opus Genetics stock analysis, traders can identify Opus Genetics position entry and exit signals to maximize returns.

When running Opus Genetics' price analysis, check to measure Opus Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics is operating at the current time. Most of Opus Genetics' value examination focuses on studying past and present price action to predict the probability of Opus Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics' price. Additionally, you may evaluate how the addition of Opus Genetics to your portfolios can decrease your overall portfolio volatility.